Navigation Links
DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases
Date:3/18/2013

GAITHERSBURG, Md., March 18, 2013 /PRNewswire/ -- DioGenix, Inc. announced today that the United States Patent and Trademark Office has issued a patent that broadly protects DioGenix' proprietary next-generation sequencing assay, MSPrecise™, that has shown in recent clinical studies to accurately identify patients with multiple sclerosis (MS) at first clinical presentation.

"This patent, combined with DioGenix' expertise in developing novel molecular tests, is a strategic necessity, as our lead clinical trial advances to validate the accuracy of MSPrecise in real-world populations being evaluated for a variety of neuroimmune diseases like MS. These rights are merely the first in a growing patent estate based on novel insights into human neurology from a series of clinical studies initiated by the combined team at DioGenix and the University of Texas Southwestern Medical Center (UTSW)," said Larry Tiffany , President and CEO of DioGenix. "Indeed, this patent is a cornerstone of our intellectual property portfolio that allows the company to pursue a longer-term strategy; building a comprehensive pipeline of tests for a variety of immune-mediated neurological diseases."

U.S. Patent 8394583 entitled "VH4 Codon Signature for Multiple Sclerosis" claims and describes the use of DNA mutational analysis to profile the immune response of patients suspected of MS across a variety of biosamples (including cerebral spinal fluid and blood) and resulting biomolecules (DNA and RNA).  Specific "hot spots" are identified where the mutational frequency of DNA changes are more prevalent in patients with MS than in other similar neurological diseases and healthy controls.

"As we continue to immunoprofile patients that are difficult to discriminate given indefinite clinical symptoms, we believe that our patented approach will allow DioGenix to develop specific DNA mutational pro
'/>"/>

SOURCE DioGenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. DioGenix and Fast Forward Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis
2. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
3. Southern Home Medical Once Again Reduces The Companys Issued And Outstanding Preferred Shares
4. Vomaris patent estate grows to six issued U.S. patents and three granted international patents with U.S. Pat. No. 8,224,439
5. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
6. NW Bio Receives U.S. Patent On Broad Processes For Producing More Potent Dendritic Cells
7. Medbox Acquires 50% of MedVend and its Patented Technologies
8. In Age of Patent Expiration, Planning Groups for New Pharma Products Growing in Importance
9. OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
10. Amedica Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
11. BioElectronics Announces Publication of Patent Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim will ... disease at the American Thoracic Society International Conference ... , May 17 – 22. Data ... for the treatment of chronic obstructive pulmonary disease ... well as investigational compounds for asthma, idiopathic pulmonary ...
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
(Date:5/19/2013)... foodies everywhere have long recognized ginger as a great ... sweet and savory dishes; now, a study from researchers ... root also may have properties that help asthma patients ... will be presented at the ATS 2013 International Conference. ... the bronchial tubes that carry air into and out ...
(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... 19, 2013 Today, Zane Benefits, ... business health insurance . Zane Benefits, which provides ... health benefits, is the leader in health care ... reimbursement arrangements . , According to Zane Benefits’ ... intrinsically know the value of small business health ...
(Date:5/19/2013)... These molecular diagnostics market reports provide ... Italy, Germany and France:,     Major ... as well as key economic, regulatory, demographic, social ... the next five years. ,     An extensive ... formats, detection methodologies, trends in testing automation and ...
(Date:5/19/2013)... Americans live closer to their dogs than ... Medical Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, ... dog a member of the family, up from the ... years earlier. , According to the American Pet Products ... dedicated to pets has increased every year without interruption, ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... May 20 - XanGo, LLC, the mangosteen beverage category ... icon, former presidential advisor, philanthropist and motivational speaker Doug ... brings to XanGo deep experience in direct selling, having ... the past 30 years. He previously served as special ...
... WILL BE SOLD ON iTUNES TO RAISE FUNDS FOR ... Will Be Donated To D.C.-Based Accelerate Brain Cancer CureLOS ... the seventh season of "American Idol," David Cook returns ... Wednesday night to perform "Permanent," -- a song he ...
... WINNIPEG, May 20 /PRNewswire/ - The Children,s Hospital ... on its newly commissioned RIVA System (Robotic Intravenous ... syringes and bags from Intelligent Hospital Systems (IH ... The Children,s Hospital of Philadelphia was rated first ...
... RALEIGH, N.C. , May 20 ... healthcare grade televisions and on-demand patient and staff interactive ... on-demand video education and entertainment system into ... expanded and renovated its facility, adding two new floors ...
... May 1st, 2009 in TEDA Tianjin, ChinaTEDA Tianjin, China, ... contract manufacturer of API,s and intermediates, and Drug Products ... opening if its high potency Active Pharmaceutical Ingredient (API) ... This dedicated facility is sited at Asymchem,s TEDA Tianjin ...
... and Healthcare Industry Leaders to Measure Impact of Patient ... A group of prominent healthcare leaders, clinicians, researchers ... Institute for Interactive Patient Care (IIPC). ... for the importance of patient engagement as a means ...
Cached Medicine News:Health News:Direct Selling Icon, Former Presidential Advisor Doug Wead Joins XanGo 2Health News:Direct Selling Icon, Former Presidential Advisor Doug Wead Joins XanGo 3Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 2Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 3Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 4Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2Health News:Institute for Interactive Patient Care Launched 2Health News:Institute for Interactive Patient Care Launched 3Health News:Institute for Interactive Patient Care Launched 4
... the advantages of the IPL Quantum DL and ... and other deeper vascular lesions. This cost-effective system ... alone device or as an upgrade to the ... range of conditions including: Leg veins ...
... powerful, versatile, and innovative aesthetic treatments to ... Light and Laser System.,With StarLux you attach ... so theres no need to buy ... choose among Laser, Intense Pulsed Light, and ...
... (Western Blot): The assay uses immortalized human ... surface. The cells are fixed to the ... uninfected T-cells are provided as a control. ... HIV- I antibodies comes in contact with ...
... say the most efficient,aspiration is ... movement of the,cannula tip. Rigorous ... ARC-H II Reciprocating Cannula,assures that ... is,restricted to a longitudinal axis ...
Medicine Products: